Yoshida M - Search Results

1

Biodistribution and in vivo antitumor efficacy of the systemically administered anti-human T-leukemia immunotoxins and potentiation of their efficacy by alpha-interferon.

Yokota S, Okazaki M, Yoshida M, Seon BK. Yokota S, et al. Among authors: yoshida m. Leuk Res. 1993 Jan;17(1):69-79. doi: 10.1016/0145-2126(93)90143-9. Leuk Res. 1993. PMID: 8429682

2

Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.

Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK. Kawata A, et al. Among authors: yoshida m. Cancer Res. 1994 May 15;54(10):2688-94. Cancer Res. 1994. PMID: 8168098

3

Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.

Okazaki M, Luo Y, Han T, Yoshida M, Seon BK. Okazaki M, et al. Among authors: yoshida m. Blood. 1993 Jan 1;81(1):84-94. Blood. 1993. PMID: 8417805 Free article.

4

Isolation and chemical characterization of the human B29 and mb-1 proteins of the B cell antigen receptor complex.

Vasile S, Coligan JE, Yoshida M, Seon BK. Vasile S, et al. Among authors: yoshida m. Mol Immunol. 1994 Apr;31(6):419-27. doi: 10.1016/0161-5890(94)90061-2. Mol Immunol. 1994. PMID: 7514267

5

Characterization and distribution of O-glycosylated carbohydrates in the cell adhesion molecule, contact site A, from Dictyostelium discoideum.

Yoshida M, Yokota S, Ouchi S. Yoshida M, et al. Exp Cell Res. 1997 Feb 1;230(2):393-8. doi: 10.1006/excr.1996.3434. Exp Cell Res. 1997. PMID: 9024799

6

A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.

Nakano T, Ikegami H, Nakamura S, Kawase T, Nishikawa H, Yokota S, Yoshida M, Tachibana T, Igarashi T, Komuta K, Higashino K. Nakano T, et al. Among authors: yoshida m. Br J Cancer. 1996 May;73(9):1096-100. doi: 10.1038/bjc.1996.211. Br J Cancer. 1996. PMID: 8624270 Free PMC article. Clinical Trial.

7

Establishment and usefulness of an anti-human CD57 IgG1 monoclonal antibody.

Tajima J, Heike Y, Kato K, Ikarashi Y, Asada-Mikami R, Yoshida M, Kasahara T, Wakasugi H. Tajima J, et al. Among authors: yoshida m. Immunol Lett. 2000 Jun 1;72(3):159-62. doi: 10.1016/s0165-2478(00)00190-5. Immunol Lett. 2000. PMID: 10880835

8

Inhibition of vitamin D3-induced cell differentiation by interferon-gamma in HL-60 cells determined by a nitroblue tetrazolium reduction test.

Yoshida M, Eguchi T, Ikekawa N, Saijo N. Yoshida M, et al. J Interferon Cytokine Res. 1995 Nov;15(11):965-71. doi: 10.1089/jir.1995.15.965. J Interferon Cytokine Res. 1995. PMID: 8590308

9

Hydralazine combined with hyperthermia enhances the effects of carboquone.

Emi Y, Maehara Y, Kusumoto T, Baba H, Takahashi I, Yoshida M, Sugimachi K. Emi Y, et al. Among authors: yoshida m. Oncology. 1994 Jul-Aug;51(4):339-43. doi: 10.1159/000227361. Oncology. 1994. PMID: 8208517

10

Apoptosis induced by etoposide in small-cell lung cancer cell lines.

Okamoto-Kubo S, Nishio K, Heike Y, Yoshida M, Ohmori T, Saijo N. Okamoto-Kubo S, et al. Among authors: yoshida m. Cancer Chemother Pharmacol. 1994;33(5):385-90. doi: 10.1007/BF00686267. Cancer Chemother Pharmacol. 1994. PMID: 8306412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,150 results

Search Page

Filters